CoChat

Outcomes Assessment following Treatment of Spasmodic Dysphonia with Botulinum Toxin

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Spasmodic dysphonia (SD), a disabling focal dystonia involving the laryngeal musculature, is most commonly treated by the intramuscular injection of botulinum toxin (BTX). Although the treatment is well tolerated and generally produces clinical voice improvement, it has never been statistically shown to alter the patient's perception of voice quality or general health. Declining resources for medical care mandate that treatment outcomes be documented. A prospective analysis of the effects of BTX on the patient's perception of voice and general health was undertaken. The Voice Handicap Index (VHI) and Short Form 36 (SF-36) surveys were administered to patients before treatment and 1 month after. Pretreatment and posttreatment scores were analyzed with a Student's t-test. On the VHI, improvements in the patients' perception of their functional, physical, and emotional voice handicap reached statistical significance (p < or = .0005). On the SF-36, patients had statistically significant improvements in mental health (p < or = .03) and social functioning (p < or = .04). Treatment of SD with BTX significantly lessened the patients' perception of dysphonia. In addition, it improved their social functioning and their perception of their mental health. These outcome measures justify the continued treatment of SD with BTX.

Overview

Integrity signals

Registry

Crossref · 10.1177/000348940010900906

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 9 references

Research works printed but not linked: 3

  1. Ludlow CL, 1994, Therapy with botulinum toxin, 437
  2. Schantz EJ, 1994, Therapy with botulinum toxin, xxii
  3. Ware JE, 1993, SF-36 Health Survey manual & interpretation guide

Cited by

See all 75

Metadata

Authors
Courey, M. S., Garrett, C. G., Portell, M. D., Billante, C. R., Smith, T. L., Stone, R. E., & Netterville, J. L.
Affiliations
  • Nashville, Tennessee
  • Milwaukee, Wisconsin
Venue
Annals of Otology, Rhinology & Laryngology
Published
2000-09
Volume
109
Issue
9
Pages
819-822
ISSN
  • 0003-4894 (ISSN-L)
  • 1943-572X
OpenAlex
W2332816826
Cited by
70
References
9
Citations by year
2026: 3 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2013: 4 · 2012: 1
FWCI
1.22
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Annals of Otology Rhinology & Laryngology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords
spasmodic dysphonia, botulinum toxin, focal dystonia, Voice Handicap Index, SF-36, voice handicap, quality of life, mental health, social functioning, treatment outcomes
MeSH terms
Adult, Aged, Botulinum Toxins, Female, Humans, Laryngeal Muscles, Male, Middle Aged, Neuromuscular Agents, Prospective Studies, Surveys and Questionnaires, Severity of Illness Index, Spasm, Voice Disorders, Voice Quality, Treatment Outcome, Patient Satisfaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes Assessment following Treatment of Spasmodic Dysphonia with Botulinum Toxin. https://app.cochat.ai/papers/10.1177/000348940010900906
The paper
Courey, M. S., Garrett, C. G., Portell, M. D., Billante, C. R., Smith, T. L., Stone, R. E., & Netterville, J. L. (2000). Outcomes Assessment following Treatment of Spasmodic Dysphonia with Botulinum Toxin. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/000348940010900906

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.